Verastem (VSTM) Return on Capital Employed (2012 - 2026)
Verastem's (VSTM) quarterly Return on Capital Employed came in at 100.34% in Q1 2026, up 6148.0% year-on-year from 1.61% in Q1 2025, and up 17.8% quarter-over-quarter from 122.06% in Q4 2025.
Verastem (VSTM) Return on Capital Employed (2012 - 2026) Analysis & Trends
Verastem's Return on Capital Employed history runs 15 years deep, the most recent figure standing at 100.34% for Q1 2026.
- On a quarterly basis, Return on Capital Employed rose 6148.0% year-over-year to 100.34% in Q1 2026; TTM through Mar 2026 was 100.34%, a 6148.0% increase from a year earlier, with the FY2025 full-year figure at 167.25%, down 4580.0% from the prior year.
- Return on Capital Employed improved to 100.34% in Q1 2026 per VSTM's latest filing, from 122.06% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 48.58% in Q3 2023 and bottomed at 161.82% in Q1 2025.
- The 5-year median for Return on Capital Employed is 91.72% (2024), against an average of 101.32%.
- Across the five-year window, Return on Capital Employed tumbled 9694 bps in 2024 and surged 6148 bps in 2026, its largest moves.
- Year by year, Return on Capital Employed stood at 89.59% in 2022, then increased by 25 bps to 67.43% in 2023, then sank by 105 bps to 138.53% in 2024, then advanced by 12 bps to 122.06% in 2025, then gained by 18 bps to 100.34% in 2026.
- Per Business Quant, the three latest VSTM Return on Capital Employed figures stand at 100.34% (Q1 2026), 122.06% (Q4 2025), and 126.33% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | Verastem | 166.09 Mn | -31.73 Mn | 15.90 Mn | -100.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -100.34% |
| Dec 31, 2025 | -122.06% |
| Sep 30, 2025 | -126.33% |
| Jun 30, 2025 | -137.79% |
| Mar 31, 2025 | -161.82% |
| Dec 31, 2024 | -138.53% |
| Sep 30, 2024 | -145.52% |
| Jun 30, 2024 | -117.19% |
| Mar 31, 2024 | -91.72% |
| Dec 31, 2023 | -67.43% |
| Sep 30, 2023 | -48.58% |
| Jun 30, 2023 | -54.74% |
| Mar 31, 2023 | -87.96% |
| Dec 31, 2022 | -89.59% |
| Sep 30, 2022 | -86.56% |
| Jun 30, 2022 | -79.08% |
| Mar 31, 2022 | -67.30% |
| Dec 31, 2021 | -66.98% |
| Sep 30, 2021 | -59.08% |
| Jun 30, 2021 | -27.02% |